PROFOUND MEDICAL CORP. Payments of Financing Costs
PROFOUND MEDICAL CORP. (PROF) reported Payments of Financing Costs of $1.02 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfFinancingCosts · last filed 2026-03-05
- PROFOUND MEDICAL CORP. payments of financing costs for the quarter ending 2024-12-31 was $3.04M.
- PROFOUND MEDICAL CORP. payments of financing costs for the quarter ending 2024-09-30 was $0.00.
- PROFOUND MEDICAL CORP. payments of financing costs for the quarter ending 2024-06-30 was $0.00.
- PROFOUND MEDICAL CORP. payments of financing costs for the quarter ending 2024-03-31 was $1.86M.
- PROFOUND MEDICAL CORP. payments of financing costs for fiscal 2025 was $1.02M, a 79.24% decline from fiscal 2024.
- PROFOUND MEDICAL CORP. payments of financing costs for fiscal 2024 was $4.89M.
| Period end | Payments of Financing Costs 3 month | Payments of Financing Costs 6 month | Payments of Financing Costs 9 month | Payments of Financing Costs 12 month |
|---|---|---|---|---|
| 2025-12-31 | $1.02M 10-K · filed 2026-03-05 | |||
| 2024-12-31 | $3.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $3.04M derived: sum of 2 quarters · filed 2026-03-05 | $3.04M derived: sum of 3 quarters · filed 2026-03-05 | $4.89M 10-K · filed 2026-03-05 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $1.86M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $1.86M 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $1.86M 10-Q · filed 2025-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |